Anti-psoriatic therapy recovers high-density lipoprotein composition and function. - Wikidata - wikimedia - TriplyDB

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

http://www.wikidata.org/entity/Q34259215

about

Atherosclerosis in psoriatic disease: latest evidence and clinical implications Management of cardiovascular disease in patients with psoriasis.The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.Metrics of High-Density Lipoprotein Function and Hospital Mortality in Acute Heart Failure Patients Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis.Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile.Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL.Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients.High-density lipoprotein cholesterol function improves after successful treatment of psoriasis: a step forward in the right direction Does treatment of psoriasis reduce the risk of cardiovascular disease?Psoriasis-associated vascular disease: the role of HDL.Liver disease alters high-density lipoprotein composition, metabolism and function.Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia.Local effects of adipose tissue in psoriasis and psoriatic arthritis.

P2860

Q26783501-DA195F15-2EEA-40EA-8ADE-54B8E394F3F9 Q30250278-575EB31F-4E3D-45DE-BBB3-F04C2BDF13BA Q35135726-4AC06B2E-5041-4144-B317-E84C91F76913 Q36052803-AEB36CDB-D7D7-45BD-B8D2-C7ADC14846FB Q36157875-3CC712FD-048E-44FD-A42C-5D087E6500AD Q36514727-37E94AAD-7A30-42ED-A5D5-944411186F4D Q36681188-AC497086-0605-4911-B324-D28FCF6DCBE3 Q36681220-347A9A8D-FC65-4885-B83B-1281C4B453A0 Q37554151-62F72ACC-1992-404E-AA6F-ADD31E0472B5 Q37593287-A1158E83-B6FD-457B-8752-A7746E9BF8B3 Q38178202-20F16D38-D465-4FD7-B4A1-6071A9F7ED6D Q41108229-88875667-A81C-4FAB-AFA4-1BFF84C6345F Q41231925-3868698A-E1A1-48EE-A273-A298E89BA90F Q41387814-F1B43608-1C89-4261-95C0-793F7CA9041A Q41908048-1BDF3D08-EBFB-4C33-AC8E-57078EA9607A Q46180528-DDFD5E54-C6F8-4EFB-813B-53288ED03AF4 Q51064399-166369F9-EA8C-4B87-9EE4-86718AE99C72 Q55440359-A3E97E16-4D6F-49CA-91E7-DAA537BE1B10

P2860

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

http://www.wikidata.org/entity/Q34259215

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@ast

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@en

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@nl

type

label

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@ast

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@en

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@nl

prefLabel

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@ast

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@en

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@nl

P1433

Q34259215-56A2C99B-6CBE-4C83-A3D9-5EA607EC512E

P1476

Q34259215-0D8D5F31-042D-421C-B8BB-58E9E24EC483

P2093

Q34259215-0AA0E643-414B-4DE3-ADB7-B41C1D95A22B

Q34259215-3C90CB2E-2CD4-4D30-9254-EFCADB1A888D

Q34259215-44C111A2-A245-47D8-88ED-44383EC76FD7

Q34259215-B41443EF-E07C-455B-9EAD-BCECB36985FD

Q34259215-DF3E3498-FFF0-46BB-84BC-9B27E5B3D628

Q34259215-EEAF5BF7-12D6-4F70-9DFC-AB11A7C101FE

P2860

Q34259215-2C217F6B-48CF-4034-B839-208DE758F38B

Q34259215-31E6A16C-7F75-422E-9CEB-1BEBE59CB976

Q34259215-39A32223-1A8B-4C03-9BD7-CD5EF6C39C6D

Q34259215-3AD4CFFB-5E50-4D9D-97FF-925169A70592

Q34259215-3FA0AFB8-59F7-4134-8BA6-53CBF84546A3

Q34259215-4415F7B0-CDD0-48FE-8470-0DBD33FB791D

Q34259215-485B7588-C586-4B14-8ED6-489B5088FC5C

Q34259215-4FED18C9-9A8E-41BD-9652-00D6470B249F

Q34259215-59BE15EA-B866-4DFD-ABA8-1460048E7303

Q34259215-62681665-EF05-4B0A-B10E-E05085C9FE48

P2888

Q34259215-5F08D55D-6B74-4F32-AB55-4AD4256AAC7A

P304

Q34259215-190A579C-1EB4-4FE3-AB9A-390213312AD3

P31

Q34259215-A628AB32-2DEE-400B-BEB2-5F6552E8C549

P356

Q34259215-ACCE90E2-4854-4A5B-A827-C7B45A1982F6

P407

Q34259215-7525B0C6-1D1F-4566-AABB-E0F2E35CEFA5

P433

Q34259215-A5E14982-1B9B-45E0-A60C-A079266C30D1

P478

Q34259215-A34EE9BD-61B1-45AF-B59D-CAF5FC848FB3

P50

Q34259215-4EE6A786-5616-44AF-87BD-396511C0AA1D

Q34259215-AB85AC5D-B17F-41E3-BD25-1D415F08629E

Q34259215-F81323F7-422A-4E3F-BE65-2F53E20E7ABA

P577

Q34259215-2C56D570-B29C-4BC4-9F5C-21C018855346

P5875

Q34259215-C05F0833-B755-4F76-933A-C9BD5E601DBE

P6179

Q34259215-14C558A9-7940-47A5-ADA7-4698B6B6E747

P698

Q34259215-81A22425-974E-4BA7-B475-DEAF58A5E844

P921

Q34259215-FCF545ED-FCB2-407C-BA2E-F626BE401A52

P932

Q34259215-566F2FDB-AA3F-413A-AA5A-074A0E3684AC

P356

P1433

Journal of Investigative Dermatology

P1476

Anti-psoriatic therapy recovers high-density lipoprotein composition and function.

@en

P2093

Lisa Pasterk

http://www.w3.org/2001/XMLSchema#string

Markus Trieb

http://www.w3.org/2001/XMLSchema#string

Martin Inzinger

http://www.w3.org/2001/XMLSchema#string

Peter Wolf

http://www.w3.org/2001/XMLSchema#string

Sanja Curcic

http://www.w3.org/2001/XMLSchema#string

Wolfgang Weger

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Uremia alters HDL composition and function

Protein carbamylation renders high-density lipoprotein dysfunctional.

Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2

Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

P2888

P304

635-642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JID.2013.359

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P50

Gunther Marsche

P577

2013-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256201540

http://www.w3.org/2001/XMLSchema#string

P6179

1042489185

http://www.w3.org/2001/XMLSchema#string

P698

23985995

http://www.w3.org/2001/XMLSchema#string

P921

P932

4178282

http://www.w3.org/2001/XMLSchema#string